swatibis80

1
Aseptic Pharma Processing Market
res
Global and Regional Analysis
Table of Content
T E K R A M
G N I S S E C O R P A M R A H P C
I T P E S A L A B
Focus on Product, Technology, Regional and
Country Analysis Analysis and Forecast
2021-2031 December 2021
O L 1 G All rights reserved at BIS Research Inc.
2
BIS Research is a leading market intelligence and
technology research company. BIS Research
publishes in- depth market intelligence reports
focusing on the market estimations, technology
analysis, emerging high- growth applications,
deeply segmented granular country-level market
data and other important market parameters
useful in the strategic decision making for
senior management. BIS Research provides
multi-client reports, company profiles,
databases, and custom research services.
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
Copyright 2021 BIS Research Inc. All Rights
Reserved. This document contains highly
confidential information and is the sole property
of BIS Research. Disclosing, copying,
circulating, quoting or otherwise reproducing any
or all contents of this document is strictly
prohibited. Access to this information is
provided exclusively for the benefit of the
people or organization concerned. It may not be
accessed by or offered whether for sale or
otherwise to any third party.
3

• Table of Content
• Executive Summary ................................
  ........................................ 13
• 1. Product Definition.............................
  ........................................ 19
• 1.1 Inclusions ...................................
  ..................................................
  ....................19
• 1.2 Exclusions....................................
  ..................................................
  ..................19
• 2. Scope of the Work .............................
  ....................................... 20
• 2.1 Overview Report Scope .......................
  ..................................................
  ........20
• 2.2 Segmentation of the Global Aseptic Pharma
  Processing Market ...............21
  2.3 Assumptions and Limitations..................
  ..................................................
  .....22 2.4 Key Questions Answered by this
  Report............................................
  ...........23 3. Research Methodology
  ..................................................
  ........... 24
• 3.1 Global Aseptic Pharma Processing Market
  Research Methodology .........24 3.2 Primary
  Data Sources .....................................
  ................................................25
  
• 3.3 Secondary Data Sources .......................
  ..................................................
  .......26
• 3.4 Market Estimation Model.......................
  ..................................................
  ........26
• 3.5 Criteria for Company Profiling................
  ..................................................
  ......27
• 4. Markets........................................
  ............................................ 28
• 4.1 Market Overview ..............................
  ..................................................
  ..............29
• Global Aseptic Pharma Processing Market Future
  Potential .....................30 4.2.1
  Ecosystem Participants ...........................
  ..................................................
  .30
• Impact of COVID-19 on the Global Aseptic Pharma
  Processing Market
• ..................................................
  ..................................................
  .......................31
• 4.3.1 Patent Analysis...........................
  ..................................................
  ...............32
• 4.3.1.1 Introduction .............................
  ..................................................
  ....................... 32

GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
4

• 5.2.3 Regulatory Framework in EU4 (Germany,
  France, Italy, Spain) and
• the U.K...........................................
  ..................................................
  .............34
• 5.2.4 Regulatory Framework in Asia-Pacific
  ..................................................
  ....35
• 5.3 Market Dynamics ..............................
  ..................................................
  .............36
• 5.3.1 Reduced Risk of High-Cost Product Loss
  ................................................36
  
• High Growth in the Generics and
  Biopharmaceuticals Markets .............37
• Growing Demand for Contract Manufacturing Organiza
  tions (CMOs) for Aseptic Manufacturing of
  Pharmaceutical Products ............37
• 5.4 Market Challenges ............................
  ..................................................
  .............38
• 5.4.1 High Capital Investment...................
  ..................................................
  .........38
• 5.4.2 Lack of Skilled Personnel
  ..................................................
  .........................38
• 5.5 Market Opportunities..........................
  ..................................................
  ...........39
• Emergence of Data within the Aseptic Processing
  Industry ...................39
• Growing Demand for Automated Products in Aseptic
  Pharma Processing at the Pharmaceutical
  Companies ........................................
  .39
• 5.5.3 Increasing Investment in
  RD...............................................
  .....................40
• 5.5.4 Competitive Landscape ....................
  ..................................................
  ........40
• 5.6 New Offerings ................................
  ..................................................
  ................41
• 5.7 Funding and Investments ......................
  ..................................................
  .......42
• 5.8 Mergers and Acquisitions .....................
  ..................................................
  ........43
• 5.9 Synergistic Activities .......................
  ..................................................
  .............43

GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
5
7.1 Global Aseptic Pharma Processing Market (by
Product).............................54 7.1.1
Corticosteroids ..................................
..................................................
........54 7.1.2 Long-Acting Beta
Agonists/Long-Acting Muscarinic Antagonists
.........55 7.1.3 Antibiotics ...................
..................................................
...............................56 7.1.4
Others............................................
..................................................
.............56 8. Region ........................
..................................................
........... 58 8.1 North America
..................................................
................................................60
8.1.1 U.S. ....................................
..................................................
.........................61 8.1.2 Canada
..................................................
..................................................
.....62 8.2 Europe ...............................
..................................................
.............................63 8.2.1
Germany...........................................
..................................................
..........65 8.2.2 U.K. ........................
..................................................
.....................................65 8.2.3
France............................................
..................................................
.............66 8.2.4 Italy ....................
..................................................
.........................................67 8.2.5
Spain............................................
..................................................
...............68 8.2.6 Rest-of-Europe...........
..................................................
................................69 8.3 Asia-Pacifi
c ................................................
..................................................
....70 8.3.1 Market Dynamics ...................
..................................................
....................71 8.3.2 Japan
..................................................
..................................................
........72 8.3.3 China .........................
..................................................
.................................73 8.3.4 India
..................................................
..................................................
..........74 8.3.5 Australia ...................
..................................................
..................................75 8.3.6
South Korea ......................................
..................................................
.........76 8.3.7 Rest-of-Asia-Pacific...........
..................................................
........................77 8.4 Rest-of-the-World
..................................................
..........................................78 9. M
arkets - Competitive Benchmarking Company
Profiles........ 79 9.1 Company Profile
..................................................
............................................80 9.2
Abbvie Inc.......................................
..................................................
................81 9.2.1 Company Overview
..................................................
...................................81 9.2.1.1 Role
of Abbvie Inc. in Global Aseptic Pharma
Processing Market .................... 81
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
6
9.2.1.2 Abbvie Inc. Product Portfolio
..................................................
......................... 82 9.2.2
Financials........................................
..................................................
...........82 9.2.3 SWOT Analysis
..................................................
..........................................84 9.3 L
onza Group........................................
..................................................
...........85 9.3.1 Company Overview
..................................................
...................................85 9.3.1.1 Role
of Lonza Group in Global Aseptic Pharma
Processing Market ................. 85
9.3.1.2 Lonza Group Product Portfolio
..................................................
..................... 85 9.3.2
Financials........................................
..................................................
...........86 9.3.3 SWOT Analysis
..................................................
..........................................87
9.4 Baxter International Inc. ....................
..................................................
............88 9.4.1 Company Overview
..................................................
...................................88 9.4.1.1 Role
of Baxter International Inc. in the Global
Aseptic Pharma Processing Market
..................................................
..................................................
.......... 88 9.4.1.2 Baxter International Inc.
Product Portfolio ................................
...................... 89 9.4.2
Financials........................................
..................................................
...........89 9.4.3 SWOT Analysis
..................................................
..........................................92 9.5 A
ugust Bioservices ................................
..................................................
.......93 9.5.1 Company Overview
..................................................
...................................93 9.5.1.1 Role
of August Bioservices in the Global Aseptic
Pharma Processing Market .........................
..................................................
...................................
93 9.5.1.2 August Bioservices Product
Portfolio.........................................
...................... 93 9.5.2 SWOT Analysis
..................................................
..........................................94 9.6 V
etter Pharma .....................................
..................................................
...........95 9.6.1 Company Overview
..................................................
...................................95 9.6.1.1 Role
of Vetter Pharma in Global Aseptic Pharma
Processing Market............... 95
9.6.1.2 Vetter Pharma Product Portfolio
..................................................
................... 95 9.6.2 SWOT Analysis
..................................................
..........................................96
9.7 Recipharm AB .................................
..................................................
...............97 9.7.1 Company Overview
..................................................
...................................97 9.7.1.1 Role
of Recipharm AB in Global Aseptic Pharma
Processing Market ............... 97
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
7

• 9.7.2 SWOT Analysis ............................
  ..................................................
  ..............99
• 9.8 Berkshire Sterile Manufacturing...............
  ..................................................
  ..100
• 9.8.1 Company Overview .........................
  ..................................................
  ........100
• 9.8.1.1 Role of Berkshire Sterile Manufacturing
  in Global Aseptic Pharma Processing Market
  ..................................................
  ....................................... 100
• 9.8.2 SWOT Analysis ..............................
  ..................................................
  ..........101
• 9.9 Recro Pharma .................................
  ..................................................
  .............102
• 9.9.1 Company Overview .........................
  ..................................................
  ........102
• 9.9.1.1 Role of Recro Pharma in Global Aseptic
  Pharma Processing Market ............. 102 9.9.2
  SWOT Analysis ....................................
  ..................................................
  ....103 9.10 Curia ..............................
  ..................................................
  ...............................104 9.10.1
  Company Overview .................................
  ..................................................
  104
• 9.10.1.1 Role of Curia in Global Aseptic Pharma
  Processing Market ........................... 104
  9.10.2 SWOT Analysis ............................
  ..................................................
  ............105 9.11 Samsung Biologics
  ..................................................
  .....................................106 9.11.1
  Company Overview .................................
  ..................................................
  106
• 9.11.1.1 Role of Samsung Biologics in the Global
  Aseptic Pharma Processing Market
  ..................................................
  ..................................................
  ........ 106
• 9.11.1.2 Samsung Biologics Overall Product
  Portfolio.........................................
  ....... 106
• 9.11.2 Financials.................................
  ..................................................
  ................107
• 9.11.3 SWOT Samsung Biologics Analysis............
  ............................................108
• 9.12 Symbiosis Pharmaceutical Services............
  ................................................10
  9
• 9.12.1 Company Overview ..........................
  ..................................................
  .......109
• Role of Symbiosis Pharmaceutical Services in the
  Global Aseptic Pharma Market ....................
  ..................................................
  ...................................... 109
• Symbiosis Pharmaceutical Services Overall
  Product Portfolio....................... 109
  9.12.2 SWOT Analysis .............................
  ..................................................
  ...........110 9.13 Catalent Pharma Solutions
  Inc. .............................................
  .......................111 9.13.1 Company
  Overview .........................................
  ..........................................111
• 9.13.1.1 Role of Catalent Pharma Solutions Inc.in
  the Global Aseptic Pharma Market
  ..................................................
  ..................................................
  ........ 111

GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
8
9.13.1.2 Catalent Pharma Solutions Inc. Overall
Product Portfolio .............................
112 9.13.2 Financials.............................
..................................................
....................112 9.13.3 SWOT Analysis
..................................................
........................................115 9.14 A
lcami Corporation ................................
..................................................
.....116 9.14.1 Company Overview
..................................................
.................................116 9.14.1.1
Role of Alcami Corporation in the Global Aseptic
Pharma Market .................. 116 9.14.1.2
Alcami Corporation Overall Product
Portfolio.........................................
....... 116 9.14.2 SWOT Analysis
..................................................
........................................117
9.15 Wuxi AppTec .................................
..................................................
...............118 9.15.1 Company Overview
..................................................
.................................118 9.15.2 Role
of Wuxi AppTec in the Global Aseptic Pharma
Processing Market................................
..................................................
.......................118 9.15.3
Financials........................................
..................................................
.........119 9.15.4 Key Insights About Financial
Health of the Company ...........................1
21 9.15.5 SWOT Analysis .........................
..................................................
...............122
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
9
List of Figures
Figure 1
Global COVID-19 Vaccination Scenario (2021)
Figure 2
Global Aseptic Pharma Processing Market,
Million, 2020-2031
Figure 3
Global Aseptic Pharma Processing Market Impact
Analysis
Figure 4
Global Aseptic Pharma Processing Market (by
Product Type), Million, 2020, 2025 and 2031
Figure 5
Global Aseptic Pharma Processing Market (by
Technology), Million, 2020, 2025, and2031
Figure 6
Global Aseptic Pharma Processing Market (by
Region), 2020 and 2031
Figure 7
Share of Key Market Strategies and Developments,
January 2017- December 2021
Figure 8
Global Aseptic Pharma Processing Market (by
Segment)
Figure 9 Global Aseptic Pharma Processing Market
Methodology Figure 10 Figure 3.2 Primary
Research Methodology Figure 11 Bottom-Up
Approach (Segment-Wise Analysis) Figure 12
Global Aseptic Pharma Processing Market,
Million, 2020-2031 Figure 13 Ecosystem
CDMOs Figure 14 Impact of COVID-19 on the Global
Aseptic Pharma Processing Market, Million,
2020-2026 Figure 15 Patent Analysis (by Year),
2018-2021 Figure 16 Global Aseptic Pharma
Processing Market, Business Dynamics Figure 17
Share of Key Market Strategies and Developments,
January 2017- December 2021 Figure 18 Share of
New Offerings (by Company), January 2017-
December 2021 Figure 19 Share of Fundings and
Investments (by Company), January 2017- December
2021 Figure 20 Share of Mergers and
Acquisitions (by Company), January 2017- December
2021 Figure 21 Share of Synergistic Activities
(by Company), January 2017- December 2021 Figure
22 Market Share Analysis for Global Aseptic
Pharma Processing Market, 2020 Figure 23 Global
Aseptic Pharma Processing Market (by
Technology) Figure 24 Global Aseptic Pharma
Processing Market (Drying), Million,
2020-2031 Figure 25 Global Aseptic Pharma
Processing Market (Lyophilization), Million,
2020-2031 Figure 26 Global Aseptic Pharma
Processing Market (Closed Vial Technology),
Million, 2020-2031 Figure 27 Global Aseptic
Pharma Processing Market (Blow-Fill-Seal
Technology), Million, 2020-2031 Figure 28
Global Aseptic Pharma Processing Market (Others),
Million, 2020-2031 Figure 29 Global Aseptic
Pharma Processing Market (by Product) Figure 30
Global Aseptic Pharma Processing Market
(Corticosteroids), Million, 2020-2031
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
10
Figure 31 Global Aseptic Pharma Processing
Market (Long-Acting Muscarinic Antagonists),
Million, 2020- 2031 Figure 32 Global Aseptic
Pharma Processing Market (Antibiotics), Million,
2020-2031 Figure 33 Global Aseptic Pharma
Processing Market (Others), Million, 2020-2031
Figure 34 Global Aseptic Pharma Processing
Market (by Region), 2020-2031 Figure 35 Share of
North America Aseptic Pharma Processing Market
Revenue (by Country), Million, 2020 and
2031 Figure 36 North America Market
Dynamics Figure 37 U.S. Aseptic Pharma
Processing Market, Million, 2020-2031 Figure
38 Canada Aseptic Pharma Processing Market,
Million, 2020-2031 Figure 39 Share of Europe
Aseptic Pharma Processing Market (by Country),
Million, 2021-2031 Figure 40 Europe Market
Dynamics Figure 41 Germany Aseptic Pharma
Processing Market Revenue, Million, 2020-2031
Figure 42 U.K. Pharma Processing Market Revenue,
Million, 2020-2031 Figure 43 France Pharma
Processing Market Revenue, Million, 2020-2031
Figure 44 Italy Pharma Processing Market
Revenue, Million, 2020-2031 Figure 45 Spain
Pharma Processing Market Revenue, Million,
2020-2031 Figure 46 Rest-of-Europe Pharma
Processing Market Revenue, Million, 2020-2031
Figure 47 Asia-Pacific Aseptic Pharma Processing
Market, Million, 2020-2031 Figure 48
Asia-Pacific Market Dynamics Figure 49 Revenue
Contributions of Various Countries in
Asia-Pacific, Million, 2020 and 2031 Figure 50
Japan Aseptic Pharma Processing Market, Million,
2020-2031 Figure 51 China Aseptic Pharma
Processing Market, Million, 2020-2031 Figure
52 India Aseptic Pharma Processing Market,
Million, 2020-2031 Figure 53 Australia Aseptic
Pharma Processing Market, Million,
2020-2031 Figure 54 South Korea Aseptic Pharma
Processing Market, Million, 2020-2031 Figure 55
Rest-of-APAC Aseptic Pharma Processing Market,
Million, 2020-2031 Figure 56 Rest-of-the-World
Aseptic Pharma Processing Market, Million,
2020-2031 Figure 57 Shares of Key Company
Profiles Figure 58 Abbvie, Inc. Overall
Financials, Million, 2018-2020 Figure 59
Abbvie, Inc. Revenue (by Region), Million,
2018-2020 Figure 60 Abbvie, Inc. RD
Expenditure, Million, 2018-2020 Figure 61
Abbvie, Inc. SWOT Analysis 10
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
11
Figure 62 Lonza Group Overall Financials,
Million, 2018-2020 Figure 63 Lonza Group RD
Expenditure, Million, 2018-2020 Figure 64
Lonza Group SWOT Analysis Figure 65 Baxter
International Inc. Overall Financials, Million,
2018-2020 Figure 66 Baxter International Inc.
Revenue (by Segment), Million, 2018-2020 Figure
67 Baxter International Inc. Revenue (by
Region), Million, 2018-2020 Figure 68 Baxter
International Inc. RD Expenditure, Million,
2018-2020 Figure 69 Baxter International Inc.
SWOT Analysis Figure 70 August Bioservices SWOT
Analysis Figure 71 Vetter Pharma SWOT
Analysis Figure 72 Recipharm AB Overall Product
Portfolio Figure 73 Recipharm AB SWOT
Analysis Figure 74 Berkshire Sterile
Manufacturing Overall Product Portfolio Figure
75 Berkshire Sterile Manufacturing SWOT
Analysis Figure 76 Recro Pharma Overall
Product Portfolio Figure 77 Recro Pharma SWOT
Analysis Figure 78 Curia Overall Product
Portfolio Figure 79 Curia SWOT Analysis Figure
80 Samsung Biologics Overall Financials,
Million, 2018-2020 Figure 81 Samsung Biologics
Revenue (by Region), Million, 2018-2020 Figure
82 Samsung Biologics SWOT Analysis Figure 83
Symbiosis Pharmaceutical Services SWOT
Analysis Figure 84 Catalent Pharma Solutions
Inc Overall Financials, 2019-2021 Figure 85
Catalent Pharma Solutions Inc Company Revenue
(by Segments), 2019-2021 Figure 86 Catalent
Pharma Solutions Inc. RD Expenditure,
2019-2021 Figure 87 Catalent Pharma Solutions
Inc. SWOT Analysis Figure 88 Alcami
Corporation SWOT Analysis Figure 89 Wuxi
AppTec Overall Product Portfolio Figure 90
Wuxi AppTec Overall Financials, 2018-2020 Figure
91 Wuxi AppTec Revenue (by Segment), 2018-2020
Figure 92 Wuxi AppTec Revenue (by Region),
2018-2020 Figure 93 Wuxi AppTec RD
Expenditure, 2018-2020 Figure 94 Wuxi AppTec
SWOT Analysis
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
11
12
Disclaimer
BIS Research Inc. provides valuable market
intelligence to an exclusive group of customers
in response to orders. The report is licensed
for the customer's internal use only and is
subject to restrictions set henceforth. This
document and its contents are confidential and
may not be further distributed, published or
reproduced, in whole or in part, by any medium
or in any form for any purpose, without the
express written consent of BIS Research Inc.
Customer will not disclose the contents of the
report, whether directly in any media or
indirectly through incorporation in a database,
marketing list, report or otherwise, or use or
permit the use of information to generate any
statistical or other information that is or will
be provided to third parties or voluntarily
produce information in legal proceedings.
Market reports are based on expectations,
estimates and projections as of the date such
information is available. Any recommendation
contained in this report may not be suitable for
all investors or businesses. The market
conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of
the date of such statements, are inherently
subject to market fluctuations and business,
economic and competitive uncertainties and
contingencies.
For more details regarding permission, please
contact us Email sales_at_bisresearch.com Tel 1
510 404 8135
GLOBAL ASEP TIC P HAR MA PROCESSING MARKET
12
13
T E K R A M G N I S S E C O R P A M
R A H P C I T P E S A L A B O
L 13 G All rights reserved at BIS Research Inc.
BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite
313 Fremont, CA 94538 -1686 E-mail
hello_at_bisresearch.com Call Us 1-510-404-8135
Global Delivery Center Tower B First Floor,
Tapasya Corporate Heights, Greater Noida
Expressway, Sector 126, Noida, U.P., 201303,
India Tel [phone]
www.bisresearch.com